686 Results

People

  1. Giralt
    Giralt
  2. Usmani
    Usmani
  3. Landgren
    Landgren
  4. Lesokhin
    Lesokhin
  5. Landau
    Landau
  6. Mailankody
    Mailankody
  7. Hassoun
    Hassoun
  8. Hultcrantz
    Hultcrantz
  9. Shah
    Shah
  10. Shah
    Shah

Groups

  1. Department of Medicine (425)
  2. Hematologic Malignancies, Division of (378)
  3. Center for Hematologic Malignancies (353)
  4. Myeloma (190)
  5. Hematologic Malignancies Research (156)
  6. Bone Marrow Transplant (145)
  7. Survivorship Research (127)
  8. Sloan Kettering Institute Postdocs (86)
  9. GSK Faculty (76)
  10. Epidemiology and Biostatistics (65)
  1. "multiple myeloma"
Formats
  1. Journal Article (519)
  2. Review (86)
  3. Research Letter (23)
  4. Editorial (17)
  5. Meeting Abstract (15)
  6. Book Section (10)
  7. Correspondence (7)
  8. Guidelines (6)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (425)
  2. Hematologic Malignancies, Division of (378)
  3. Center for Hematologic Malignancies (353)
  4. Myeloma (190)
  5. Hematologic Malignancies Research (156)
  6. Bone Marrow Transplant (145)

More Groups

People
  1. Sergio Giralt (95)
  2. Saad Usmani (77)
  3. Carl Landgren (76)
  4. Alexander Lesokhin (66)
  5. Heather Landau (55)
  6. Sham Mailankody (55)

More People

Years
  1. 2025 (34)
  2. 2024 (83)
  3. 2023 (85)
  4. 2022 (49)
  5. 2021 (25)
  6. 2020 (47)

More Years

Publications
  1. Blood (37)
  2. Clinical Lymphoma, Myeloma and Leukemia (34)
  3. Biology of Blood and Marrow Transplantation (33)
  4. Leukemia and Lymphoma (21)
  5. Blood Cancer Journal (20)
  6. British Journal of Haematology (20)

More Publications

Publishers
  1. Elsevier Inc. (124)
  2. Nature Publishing Group (84)
  3. American Society of Hematology (48)
  4. Springer (34)
  5. John Wiley & Sons (30)
  6. Taylor & Francis Group (26)

More Publishers

Results (686)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic factors for postrelapse survival after ex vivo CD34(+)-selected (T cell-depleted) allogeneic hematopoietic cell transplantation in multiple myeloma
    Journal Article

    Gomez-Arteaga, A.; Shah, G. L.; Baser, R. E.; Scordo, M.; Ruiz, J. D.; Bryant, A.; Dahi, P. B.; Ghosh, A.; Lahoud, O. B.; Landau, H. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Summary of the 2019 Blood and Marrow Transplant Clinical Trials Network Myeloma Intergroup Workshop on Minimal Residual Disease and Immune Profiling
    Review

    Holstein, S. A.; Howard, A.; Avigan, D.; Bhutani, M.; Cohen, A. D.; Costa, L. J.; Dhodapkar, M. V.; Gay, F.; Gormley, N.; Green, D. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Impact of preemptive therapy for cytomegalovirus on hospitalizations and cost after hematopoietic stem cell transplantation
    Journal Article

    Fang, J.; Su, Y.; Zavras, P. D.; Raval, A. D.; Tang, Y.; Perales, M. A.; Giralt, S.; Stern, A.; Papanicolaou, G. A.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Hypofibrinogenemia and disseminated intravascular coagulation rarely complicate treatment-naìˆve acute lymphoblastic leukemia
    Correspondence

    Gaulin, C.; Chan, A.; Derkach, A.; Park, J. H.; Mantha, S.; Geyer, M. B.; Tallman, M. S.
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
    Journal Article

    Rowinsky, E. K.; Paner, A.; Berdeja, J. G.; Paba-Prada, C.; Venugopal, P.; Porkka, K.; Gullbo, J.; Linder, S.; Loskog, A.; Richardson, P. G.; more...
    Investigational New Drugs (2020)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft minimal residual disease negativity with novel induction regimens in multiple myeloma
    Journal Article

    Bal, S.; Landau, H. J.; Shah, G. L.; Scordo, M.; Dahi, P.; Lahoud, O. B.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Accelerated single cell seeding in relapsed multiple myeloma
    Journal Article

    Landau, H. J.; Yellapantula, V.; Diamond, B. T.; Rustad, E. H.; Maclachlan, K. H.; Gundem, G.; Medina-Martinez, J.; Arango Ossa, J.; Levine, M. F.; Zhou, Y.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Management of multiple myeloma during COVID-19 pandemic
    Review

    Jethava, Y. S.; Fonseca, R.; Landgren, O.
    Leukemia Research Reports (2020)

    Fulltext@MSK | Save
  • Carfilzomib, dexamethasone, and daratumumab versus carfilzomib and dexamethasone for patients with relapsed or refractory multiple myeloma (CANDOR): Results from a randomised, multicentre, open-label, phase 3 study
    Journal Article

    Dimopoulos, M.; Quach, H.; Mateos, M. V.; Landgren, O.; Leleu, X.; Siegel, D.; Weisel, K.; Yang, H.; Klippel, Z.; Zahlten-Kumeli, A.; more...
    Lancet (2020)

    Fulltext@MSK | Save
  • African American patients with multiple myeloma: Optimizing care to decrease racial disparities
    Review

    Pierre, A.; Williams, T. H.
    Clinical Journal of Oncology Nursing (2020)

    Fulltext@MSK | Save